Trump doesn’t have a clue about healthcare
In a press briefing Monday morning, President Donald Trump said, according to multiple news outlets, that, "Nobody knew that healthcare could be so complicated."
Reform healthcare payment while interest rates are low, says ex-HHS Secretary Leavitt
If and when rates rise again, the cost of debt service will be competing with healthcare and a couple other major components of the federal budget for ever scarcer dollars, Leavitt explained at HIMSS17 this week.
Solving Healthcare’s Provider Data Problem Starts with Interoperability
Break down the silos. Take control of your provider data.
Grassley opens probe into Orphan Drug Act abuses
In a statement, Grassley said the inquiry is “based on reporting from Kaiser Health News” and strong consumer concern about high drug prices.
New home health rules focus on care coordination, patients’ rights
The new rules are set to go into effect in July, but they may be delayed as President Donald Trump’s administration reviews regulations that have been drafted or finalized but not yet implemented.
Conservatives getting antsy over ACA repeal
Sen. Mike Lee (R-Utah) one of the leading conservative voices in that chamber, said he will vigorously oppose efforts for Republicans to wait until they have a plan ready to replace the law before they repeal it.
Price made dozens of health stock trades even as committee was investigated
Craig Holman, government affairs lobbyist with Public Citizen, described Price’s volume of stock trades during the SEC inquiry as “brazen,” given the congressman’s access to nonpublic information affecting the companies’ fortunes.
presented by
The Top 5 Home Care Franchise Opportunities in the U.S.
The home care industry is booming. As Baby Boomers age and more families seek in-home solutions for loved ones, demand for home care services is at an all-time high.
Repeal and replace turns to ‘fixing’ Obamacare as AARP rattles sabers
There's long been an unwritten rule in Washington: Don't piss off seniors, because they vote in higher percentages than younger demographics.
HHS nominee Price clears Senate committee with no Democrats present (updated)
Senate Finance Committee Chairman Sen. Orrin Hatch (R-Utah) suspended rules requiring a quorum for a vote, allowing Price to advance to the full Senate.
Rogue social media movement expands to HealthCare.gov ads
Actor/comedian Colton Dunn, of "Superstore" on NBC, has picked up the slack, posting a series of low-budget but effective videos as alternative ads for HealthCare.gov.
HHS scientists get in on ‘rogue’ social media
@AltHHS describes itself as "Unofficial and unaffiliated resistance account by concerned scientists for humanity."
presented by
Navina’s AI Copilot Eases the Value-Based Burden, Study Shows
A new independent study from Phyx Primary Care’s Innovation Lab points to measurable improvements in physician burnout, documentation efficiency, and key VBC metrics among primary care practices.
Price grilled over Medicare innovation, Medicaid block grants
Senate Finance Committee ranking member Ron Wyden (D-Oregon) was rather relentless in questioning Price.
At least 6 senators grilling HHS nominee Tom Price also hold healthcare stocks
At least six members of the two Senate committees tasked with questioning or confirming Tom Price for HHS secretary hold shares in healthcare companies — such as Merck, Medtronic and Gilead — according to a Kaiser Health News analysis.
Tom Price’s top backer told employees to give to PAC
The PAC was operated by Georgia-based MiMedx, whose CEO Parker H. “Pete” Petit is among the top individual contributors to Price. Federal election law prohibits corporations from coercing employees to contribute to PACs.
Australian biotech company offered sweetheart investment deal to Tom Price
Price told HHS ethics officials Thursday that if appointed to be HHS secretary, he will divest himself of the Australian stock as well as stock in about 40 other companies that could pose conflicts.
Consumer tech companies developing OTC hearing aids
Several recent developments are of note as consumer electronics companies, hearing aid manufacturers, audiologists, physicians, consumer advocates and regulators prepare for a surge of new hearing devices and changes in the hearing healthcare system.